✉ The Friday AI Brief: the week's 5 best AI stories, tools & comparisons — in your inbox every Friday morning.

Lexie B2 Plus

Lexie B2 Plus Review 2026: Good OTC Hearing Aids — But the Company Is Winding Down

Research reviewed October 2026. This is a research-based review — we analyzed published specs, pricing, and user feedback.

Quick verdict

✓ Best for:Existing owners who already have a working pair fitted in the app.
✕ Skip it if:You're buying new: LXE Hearing is winding down US operations and support ended September 15, 2026.

Lexie B2 Plus Review 2026: Good OTC Hearing Aids — But the Company Is Winding Down

TL;DR: The Lexie B2 Plus Powered by Bose was one of the best over-the-counter hearing aids you could buy — Bose sound technology, in-app self-fitting hearing test, call streaming, and a HearAdvisor Expert Choice Award at $899 a pair. But LXE Hearing is winding down its US operations, with support and warranties guaranteed only through September 15, 2026. Based on specs, pricing, and published reviews, the hardware is genuinely good; the company behind it is the problem. We can’t recommend buying a pair today.

Bottom line: Excellent discontinued hardware from a company that’s exiting. Don’t pay full price — if you already own a pair, keep using it; if you’re shopping, look at OTC hearing aids from companies with ongoing support.

Key features

  • Bose-powered sound: Developed with Bose’s audio technology, with treble and bass adjustments to make voices sound natural. Independent HearAdvisor lab testing rated it highly enough to earn an Expert Choice Award.
  • Self-fitting in-app hearing test: The Lexie app walks you through a hearing test at home and tunes the aids to your profile — clinically validated fitting without an audiologist visit.
  • Call streaming: Bluetooth streams phone calls on both iPhone and Android. Note the limitation: it’s tuned for calls, not music or video — media streaming is possible but not optimized.
  • Customizable listening: Four preset environment programs plus up to 10 custom environments you can create for specific situations, with background noise reduction and feedback cancellation.
  • Rechargeable: Up to 18 hours per charge, with the portable charging case holding an additional full charge for on-the-go top-ups.
  • Remote support (while it lasted): Lexie offered in-app access to hearing experts for remote help — a standout feature that’s now uncertain given the wind-down.

Who it’s for

The B2 Plus was designed for adults with mild to moderate hearing loss who want a quality OTC option without clinic visits or prescription prices. At $899 a pair, it sat in the sweet spot: far cheaper than prescription aids, far more capable than budget amplifiers. If you already own a pair and it works for you, there’s no reason to stop using it — just know that support is no longer guaranteed.

For new buyers in October 2026, the honest answer is different: this product’s support window has closed. Buy it only if you find steep clearance pricing, understand the app could stop working, and accept that warranty service may be unavailable.

What to watch out for

The wind-down is the whole story now. According to reporting updated in July 2026, LXE Hearing is winding down US operations: support and warranties were guaranteed only through September 15, 2026, and the Lexie app — which runs the hearing test and all adjustments — may stop working after that. The aids can’t be properly set up or retuned without the app, so this is a functional risk, not just a paperwork one. HearingTracker has stated it cannot currently recommend purchasing Lexie products.

Even before the wind-down, the B2 Plus had real limitations worth knowing: no music or media streaming optimization (calls only, really), no hands-free calling, modest 18-hour battery next to newer rivals’ 32 hours, and mild-to-moderate loss only — it’s not suitable for severe hearing loss. There’s no substitute here for a proper hearing evaluation, which can rule out medical issues an OTC device will never catch.

If you’re shopping for OTC hearing aids now, compare current models from companies actively supporting their products — and get your hearing checked by a professional first.

Pros and cons

Pros:

  • Bose-powered sound quality that won independent lab awards
  • Self-fitting in-app hearing test — no clinic visit needed
  • Call streaming on iPhone and Android
  • Rechargeable with portable charging case
  • Strong value at $899 a pair when it was fully supported

Cons:

  • Company winding down US operations — support and warranties no longer guaranteed
  • Lexie app may stop working, which would break setup and adjustments
  • No music/media streaming optimization; no hands-free calling
  • 18-hour battery is modest versus newer OTC rivals
  • Mild to moderate hearing loss only

Frequently asked questions

Is Lexie still in business?
LXE Hearing is winding down its US operations. Support and warranties were guaranteed only through September 15, 2026, and the future of the Lexie app is uncertain.

Should I buy the Lexie B2 Plus in 2026?
Not at full price. The hardware is good, but with support ended and the app’s future uncertain, the risk outweighs the savings. Consider it only at steep clearance prices with eyes open.

I already own the B2 Plus. What should I do?
Keep using it — the aids still work. Make sure your fitting is saved in the app now, keep the charging case handy, and start researching alternatives in case you need support later.

Does the B2 Plus stream music?
Technically yes, but it’s not optimized for music or video — Bluetooth streaming is designed for phone calls, and reviewers note media sounds mediocre.

Do I need a hearing test before buying OTC hearing aids?
OTC aids are for adults with perceived mild to moderate loss, but a professional evaluation first is strongly recommended — it rules out medical causes a device can’t fix.

Price and availability

The Lexie B2 Plus listed at $899 a pair. We are deliberately not including an Amazon purchase link: with the company’s US support wound down and the companion app’s future uncertain, we don’t think buying one at typical prices is a good idea right now. If you see clearance stock at a steep discount and accept the risks above, that’s your call — but go in with eyes open.

Leave a Comment

Your email address will not be published. Required fields are marked *

Get the 5 best AI tools every week

Top AI news, tools, and prompts — one short email. Free, unsubscribe anytime.

Run a newsletter of your own? Monetize and grow it with SparkLoop →

Scroll to Top